UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
photos

Faculty Profiles

Gabriel Mannis, MD
M_MED-HMON-CORE-ONCO-GEN
Assistant Professor

400 Parnassus Avenue
San Francisco, CA 94117
415-353-2421

Education and Training

Location Degree or Training Specialty Date
Harvard University B.A. Romance Languages and Literature
University of California, San Francisco Fellowship, Hematology/Oncology
University of California, Davis M.D.
University of California, San Francisco Internship/Residency, Internal Medicine

Interests

Acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), acute promyelocytic leukemia (APL), aplastic anemia, cancer immunotherapy, chimeric antigen receptor (CAR) T cells, end-of-life care, graft vs host disease (GVHD), hematopoietic stem cell transplantation, measurable residual disease (MRD) assessment, multiple myeloma, myelodysplastic syndrome (MDS), myeloproliferative neoplasms, palliative care, patient/trainee education., survivorship care

Awards and Honors
2014   American Society of Hematology Research Training Award, Senior Investigator, 2014
2013   UCSF Clinical Fellow Award, Hematology/Oncology Division, 2013
2013   Edward S. Ageno Family Endowed Fellowship in Hematology, 2013
2012   UCSF Clinical Fellow Award, Hematology/Oncology Division, 2012
2011   UCSF Teaching Excellence Award for Cherished Housestaff (T.E.A.C.H.), 2011
2011   UCSF Internal Medicine Professionalism Award, 2011
2008   UC Davis Ernest M. Gold Award for Excellence in Internal Medicine, 2008
2007   Major C.W. Offutt VA Medical Center Award, 2007
2007   Alpha Omega Alpha Medical Honor Society, 2007
2005   Howard Hughes Medical Institute (HHMI) - National Institutes of Health (NIH) Research Scholar, 2005
2000   Harvard College Scholarship, 2000

Recent Articles (15)

Gupta NK, Wang CC, Mannis GN, Yu JJ, Rubenstein JL. Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy. Leuk Lymphoma. 2017 Apr 10; 1-4.

Eckhert EE, Schoenbeck KL, Galligan D, McNey LM, Hwang J, Mannis GN. Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant. Bone Marrow Transplant. 2017 Mar 13.

Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2016 Aug 30.

Mulé MP, Mannis GN, Wood BL, Radich JP, Hwang J, Ramos NR, Andreadis C, Damon L, Logan AC, Martin TG, Hourigan CS. Multigene Measurable Residual Disease Assessment Improves AML Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 Aug 17.

Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KM, Sayre PH, Wolf JL, Logan AC. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Jun; 22(6):1030-6.

Mannis TE, Mannis GN, Waterhouse EG, Aldave AJ, Rose-Nussbaumer J. Paraproteinemic Keratopathy as the Presenting Sign of Hematologic Malignancy. Am J Hematol. 2016 Feb 12.

Mannis GN, McNey LM, Gupta NK, Gross DM. The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care. Am J Hematol. 2016 Jun; 91(4):364-5.

Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leuk Lymphoma. 2016 Jul; 57(7):1560-6.

Byrne M, Mannis GN, Nair J, Andreadis C. Inferior vena cava filter thrombosis. Clin Case Rep. 2016 Feb; 4(2):162-4.

Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG. A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):377-83.

Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, Venstrom JM, Wolf JL, Caballero L, Emi N, Martin TG. Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4.

Mannis G, Wu D, Dea T, Mauro T, Hsu G. Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia. Am J Hematol. 2015 Feb; 90(2):179.

Rubenstein JL, Gupta NK, Mannis GN, Lamarre AK, Treseler P. How I treat CNS lymphomas. Blood. 2013 Oct 3; 122(14):2318-30.

Mannis GN, Fehniger JE, Creasman JS, Jacoby VL, Beattie MS. Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing. JAMA Intern Med. 2013 Jan 28; 173(2):96-103.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.